• Citer

Is the protein expression window during testicular development affected in patients at risk for stem cell loss?

par Van Saen, Dorien;Pino Sánchez, J.;Ferster, Alina ;van der Werff Ten Bosch, Jutte;Tournaye, Herman;Goossens, Ellen
Référence Human reproduction, 30, 12, page (2859-2870)
Publication Publié, 2015-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

studyquestion: Is the protein expression windowduring testicular development affected in prepubertal patients at risk for stem cell loss? summary answer: Nuclear ubiquitin carboxyl-terminal esterase L1 (UCHL1) expression in Sertoli cells and interstitial expression of inhibin a (INHA), sex-determining region Y-box 9 (SOX9) and steroidogenic acute regulatory protein (STAR) was affected in patients with Klinefelter syndrome. what is known already: Some patients undergoing testicular tissue banking have already been treated before the testis biopsy is taken. These treatments include chemotherapy or hydroxyurea, which can have an influence on the stem cell number and function. A germinal loss occurs in Klinefelter patients, but its cause is currently unknown. study design, size, duration: Parrafin-embedded testicular tissue from 5 fetuses, 25 prepubertal patients and 5 adultswas used to characterize the spatial and temporal distribution of different testicular marker proteins during testicular development. Expression of the markers was evaluated in germ cells, Sertoli cell and interstitial cells. The integrity of this time window was analyzed in patients at risk for germ cell loss: patients treated with hydroxyurea (n 7), patients treated with chemotherapy (n 6) and patients affected by Klinefelter syndrome (n 5). participants/materials, setting, methods: Immunohistochemistry was performed in normal fetal, prepubertal and adult testicular tissue to set up a timeline for the expression of melanoma antigen family A4 (MAGE-A4), ubiquitin carboxyl-terminal esterase L1 (UCHL1), octamer-binDing transcription factor 4 (OCT4), stage-specific embryonic antigen-4 (SSEA4), homeobox protein NANOG, INHA, anti-Müllerian hormone, androgen receptor (AR), SOX9 and STAR. The established timeline was used to evaluate whether the expression of these markers was altered in patients at risk for germ cell loss (patients treated for sickle cell disease (hydroxyurea) or cancer (chemotherapy) and patients with Klinefelter syndrome). main results and the role of chance: Aprotein expression timeline was created using different markers expressed in different testicular cell types. Less positive tubules and less positive cells per tubule were observed for MAGE-A4 and UCHL1 expression in the KS compared with the non-treated group (P , 0.01). Higher nuclear UCHL1 Sertoli cell expression was observed in the KS group compared with the non-treated group (P , 0.05). Higher interstitial expression of INHA (P , 0.05), SOX9 (P , 0.01) and STAR (P , 0.05) was observed in KS compared with the non-treated group. limitations, reasons for caution: Important age variations exist in the prepubertal groups. Therefore, datawere represented in three age groups. However, owing to the limited access to prepubertal tissue, no statistical comparison was possible between these groups. For the Klinefelter group, tissue was only available from patients older than 12 years. wider implications of the findings: The expression timeline can add knowledge to the process of spermatogenesis and be used to evaluate altered protein patterns in patients undergoing potentially gonadotoxic treatments, to monitor spermatogenesis established in vitro and to unravel causes of germ cell loss in Klinefelter patients.